Dilated cardiomyopathy secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Dilated cardiomyopathy}} | |||
{{CMG}}; {{AE}}{{AIA}} | {{CMG}}; {{AE}}{{AIA}} | ||
== Overview == | == Overview == | ||
Patients with dilated cardiomyopathy are recommended to perform lifestyle changes, physical activity, reduce stress, and adhere to their medications. Also, patients with DCM with high risk features for sudden cardiac death are usually referred for implantable cardioverter defibrillator (ICD) placement. | |||
Patients with dilated cardiomyopathy are recommended to perform lifestyle changes, physical activity, reduce stress, and adhere to their medications. Also, patients with DCM with high risk features for sudden cardiac death are usually referred for implantable cardioverter defibrillator (ICD) placement. | |||
== Secondary Prevention == | == Secondary Prevention == | ||
For patients who suffer from dilated cardiomyopathy, the following is recommended: | For patients who suffer from dilated cardiomyopathy, the following is recommended: | ||
| Line 15: | Line 11: | ||
* Adherence to medications to avoid worsening of the condition. | * Adherence to medications to avoid worsening of the condition. | ||
* Also, patients with DCM with high risk features for sudden cardiac death are usually referred for implantable cardioverter defibrillator (ICD) placement.<ref name="pmid28355432">{{cite journal |vauthors=Al-Khatib SM, Fonarow GC, Joglar JA, Inoue LYT, Mark DB, Lee KL, Kadish A, Bardy G, Sanders GD |title=Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis |journal=JAMA Cardiol |volume=2 |issue=6 |pages=685–688 |date=June 2017 |pmid=28355432 |doi=10.1001/jamacardio.2017.0630 |url=}}</ref><ref name="pmid15152060">{{cite journal |vauthors=Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH |title=Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy |journal=N. Engl. J. Med. |volume=350 |issue=21 |pages=2151–8 |date=May 2004 |pmid=15152060 |doi=10.1056/NEJMoa033088 |url=}}</ref | * Also, patients with DCM with high risk features for sudden cardiac death are usually referred for implantable cardioverter defibrillator (ICD) placement.<ref name="pmid28355432">{{cite journal |vauthors=Al-Khatib SM, Fonarow GC, Joglar JA, Inoue LYT, Mark DB, Lee KL, Kadish A, Bardy G, Sanders GD |title=Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis |journal=JAMA Cardiol |volume=2 |issue=6 |pages=685–688 |date=June 2017 |pmid=28355432 |doi=10.1001/jamacardio.2017.0630 |url=}}</ref><ref name="pmid15152060">{{cite journal |vauthors=Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH |title=Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy |journal=N. Engl. J. Med. |volume=350 |issue=21 |pages=2151–8 |date=May 2004 |pmid=15152060 |doi=10.1056/NEJMoa033088 |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 17:11, 16 December 2019
|
Dilated cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dilated cardiomyopathy secondary prevention On the Web |
|
American Roentgen Ray Society Images of Dilated cardiomyopathy secondary prevention |
|
Risk calculators and risk factors for Dilated cardiomyopathy secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]
Overview
Patients with dilated cardiomyopathy are recommended to perform lifestyle changes, physical activity, reduce stress, and adhere to their medications. Also, patients with DCM with high risk features for sudden cardiac death are usually referred for implantable cardioverter defibrillator (ICD) placement.
Secondary Prevention
For patients who suffer from dilated cardiomyopathy, the following is recommended:
- Follow the same recommendations for primary prevention as lifestyle changes, physical activity, and reducing stress.
- Adherence to medications to avoid worsening of the condition.
- Also, patients with DCM with high risk features for sudden cardiac death are usually referred for implantable cardioverter defibrillator (ICD) placement.[1][2]
References
- ↑ Al-Khatib SM, Fonarow GC, Joglar JA, Inoue L, Mark DB, Lee KL, Kadish A, Bardy G, Sanders GD (June 2017). "Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis". JAMA Cardiol. 2 (6): 685–688. doi:10.1001/jamacardio.2017.0630. PMID 28355432. Vancouver style error: initials (help)
- ↑ Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH (May 2004). "Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy". N. Engl. J. Med. 350 (21): 2151–8. doi:10.1056/NEJMoa033088. PMID 15152060.